💉Long-lasting insulin from elilillyco—sounds pretty life-changing to us! Local leading expert Dr. Athena Philis-Tsimikas at San Diego’s scrippshealth Whittier Diabetes Institute helped deliver good news for folks living with type 2 diabetes: Lilly's long-lasting insulin product, efsitora alpha, could be debuting as early as 2026. The Phase 3 clinical trial showed improvement in helping control blood sugar through an easy once-a-week injection, rather than daily, and the investigating team is expected to request FDA approval shortly. #SDlifechanging #sandiego #research #sandiegoresearch #lifesciences